Table 4.
Change in the NIH-CPSI total and domain scores from baseline to treatment termination (n=8)
| Measure | Mean | SD | Significance |
|---|---|---|---|
| NIH-CPSI Total baseline | 23.50 | 10.73 | .007 |
| NIH-CPSI Total follow-up | 16.25 | 7.42 | |
| NIH-CPSI Urinary baseline | 4.12 | 3.76 | .087 |
| NIH-CPSI Urinary follow-up | 3.25 | 3.10 | |
| NIH-CPSI Pain baseline | 11.25 | 5.00 | .015 |
| NIH-CPSI Pain follow-up | 7.87 | 5.08 | |
| NIH-CPSI QoL impact baseline | 8.12 | 3.68 | .013 |
| NIH-CPSI QoL impact follow-up | 5.12 | 2.36 |
NIH-CPSI: National Institutes of Health/Chronic Prostatitis Symptom Index (NIH-CPSI); QoL: Quality of Life. BOLD: significant result; SD: standard deviation.